ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Allarity Therapeutics (NASDAQ:ALLR)
LOS ANGELES, Oct. 23, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or “the Company”) ALLR for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and …